# Tabula Rasa HealthCare

> Tabula Rasa HealthCare developed MedWise medication-risk technology and paired it with clinical pharmacy, dispensing, pharmacy benefits and PACE support services. Founded by Calvin and Orsula Knowlton in 2009, it combined with ExactCare in November 2023 following a Nautic-backed acquisition. The TRHC brand retired in July 2024 as the combined business became AnewHealth.

- **Founded:** 2009
- **Headquarters:** Moorestown, United States
- **Founders:** Calvin H. Knowlton (Co-founder; former Chairman and CEO), Orsula V. Knowlton (Co-founder; former President and executive leader)
- **Products:** MedWise Science and MedWise Risk Score, CareKinesis PACE Pharmacy, Pharmastar, Capstone Risk Adjustment Services, PACE clinical and administrative support
- **Notable:** Developed a regimen-based medication-risk score studied in PACE and Medicare populations., A 2020 retrospective study examined 1,965 PACE participants and found associations between the score, adverse drug events and utilization., A 2021 observational Medicare study analyzed outcomes for 203,630 patients after starting with claims from 213,561 beneficiaries.

## Products & services

- **MedWise Science and MedWise Risk Score** — Proprietary clinical decision support and regimen-based risk assessment, incorporating cumulative medication burdens and multidrug interactions; continues within AnewHealth.
- **CareKinesis PACE Pharmacy** — Clinical pharmacist support, medication-risk mitigation, dispensing and delivery for PACE participants; established in 2009 and remains an AnewHealth brand.
- **Pharmastar** — Pharmacy benefit management and pharmacy network services; part of the combined AnewHealth portfolio.
- **Capstone Risk Adjustment Services** — Risk adjustment, documentation, coding and associated provider support; part of AnewHealth.
- **PACE clinical and administrative support** — Program consulting and technology-enabled support historically offered through CareVention, including Mediture and related services.
- **AnewHealth End-to-End Pharmacy Care Management** — Successor offering combines population reports, patient-level medication surveillance and comprehensive pharmacy care.

## Achievements

- Developed a regimen-based medication-risk score studied in PACE and Medicare populations.
- A 2020 retrospective study examined 1,965 PACE participants and found associations between the score, adverse drug events and utilization.
- A 2021 observational Medicare study analyzed outcomes for 203,630 patients after starting with claims from 213,561 beneficiaries.
- Listed on Nasdaq in 2016; taken private following the 2023 acquisition.

## Latest updates

- **2026-09** — AnewHealth celebrated National PACE Month with its CareKinesis network and a video message from CEO Brian Adams.
- **2026-07** — AnewHealth published priorities from its PACE summit: PACE-specific execution, earlier medication-risk identification and closer clinical-team integration.
- **2025-01** — Brian Adams succeeded John Figueroa as AnewHealth CEO, effective January 1.
- **2024-07** — AnewHealth launched; TRHC and CareVention brand names retired.

## Links

- Website: https://anewhealthrx.com/
- LinkedIn: https://www.linkedin.com/company/tabula-rasa-healthcare/
- Twitter/X: https://twitter.com/TabulaRasaHC
- Facebook: https://facebook.com/pages/Tabula-Rasa-HealthCare-Inc/1026694124159571

---

Profile page: https://yespress.io/tabula-rasa-healthcare
Published by YesPress — https://yespress.io
Last updated: 2026-09-30